Fujifilm and Juntendo Hospital in Japan have developed an AI that can accurately predict the risk of falls among outpatients using hospital data.
Their research team collated over 500 features associated with falls, including age and prescription history, from hospital data collected in Fujifilm's CITA Clinical Finder. The data platform is used to centrally manage data across various hospital...
Southeast Asian startup leverages generative AI to simplify complex health data
A startup based in Malaysia and Singapore is coming up with a platform that leverages generative AI to simplify complex health data into comprehensible content.
Based on a press release, SayHeart has developed an algorithm that can seamlessly translate medical jargon, health reports, and complex imaging into "visual...
Medical IP gets US FDA nod for AI body composition analysis software
South Korean medical imaging company Medical IP has obtained a United States Food and Drug Administration 510(k) clearance for its AI-powered body composition analysis software.
According to the company, DeepCatch is the first FDA-approved AI software that automatically analyses body components, such as skin, bone, muscle,...
SpassMed scores US FDA 510(k) for AI sepsis detection software
South Korean medical AI company SpassMed has received the United States Food and Drug Administration's 510(k) clearance for its AI-powered sepsis detection software.
The AI solution called SpassageQ has been approved as software as a medical device for identifying sepsis, anaphylaxis, and hypovolemic shock.
South Korean researchers...
South Korea clears Coreline Soft's AI brain haemorrhage detection software
An AI-powered brain haemorrhage detection software by medtech company Coreline Soft is now listed as a non-insured medical device in South Korea following its approval from the Ministry of Food and Drug Safety.
The software product called AVIEW Neuro CAD automatically detects cerebral haemorrhages in brain CT scans and...
Direct-to-patient healthcare company Ro announced an agreement with the National Institute on Aging (NIA) to develop the Registry for Equal Access to Clinical Trials in Alzheimer's Disease (REACT-AD).
Ro will employ its telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer's disease (AD) or other related dementia to join REACT-AD for potential participation...
Lunit has partnered with Fujifilm Thailand and Microsoft to bring its AI radiology solutions to Bumrungrad International Hospital, a private hospital based in Bangkok.
According to a press statement, Lunit is deploying its chest x-ray analysis software INSIGHT CXR and mammography tool INSIGHT MMG in the hospital.
Together with Fujifilm Thailand, Lunit will supply its AI solutions to Bumrungrad...
Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision support solutions for portable and stationary chest x-ray machines.
Annalise CXR Edge is a software as a medical device that assists clinicians and radiologists in interpreting chest x-rays. According to the company, its AI algorithm identifies and notifies suspected findings in under 10...
Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer's disease within two years.
According to a press statement, the AI Technology for AD Progression Prediction has been found to have high generalisability, predicting patients who would progress to AD with high accuracy, even for subjects from different...
Multinational medical imaging device maker Fujifilm Corporation has received the approval of Japan's Pharmaceuticals and Medical Devices Agency for its latest AI-powered chest x-ray software.
WHAT IT DOES
The Fujifilm CXR-AID detects major abnormal findings from chest radiographs, such as chest nodule, consolidation and pneumothorax.
Based on a press statement, the diagnostic system runs on...
